Anam Bilgrami

Dr. Anam Bilgrami

The Macquarie University Centre for the Health Economy (MUCHE), Suite 3-4, Level 1 EMC2 Building 3, Innovation Rd, Macquarie Park, NSW 2109, Australia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2020 in Health Economics
Verified
Journal Article
Closed access
PDF file
Anam BilgramiAnam Bilgrami
Anam Bilgrami
KSKompal Sinha
Kompal Sinha
HCHenry Cutler
Henry Cutler

20 February 2023 in Social Science & Medicine
Verified
Journal Article
Open access
AAAntonio Ahumada-Canale
Antonio Ahumada-Canale
VJVarinder Jeet
Varinder Jeet
Anam BilgramiAnam Bilgrami
Anam Bilgrami
ESElizabeth Seil
Elizabeth Seil
YGYuanyuan Gu
Yuanyuan Gu
HCHenry Cutler
Henry Cutler
Health care budgets in high-income countries are having issues coping with unsustainable growth in demand, particularly in the hospital setting. Despite this, implementing tools systematising priority setting and resource allocation decisions has been challenging. This study answers two questions: (1) what are the barriers and facilitators to implementing priority setting tools in the hospital setting of high-income countries? and (2) what is their fidelity? A systematic review using the Cochrane methods was conducted including studies of hospital-related priority setting tools reporting barriers or facilitators for implementation, published after the year 2000. Barriers and facilitators were classified using the Consolidated Framework for Implementation Research (CFIR). Fidelity was assessed using priority setting tool's standards. Out of thirty studies, ten reported program budgeting and marginal analysis (PBMA), twelve multi-criteria decision analysis (MCDA), six health technology assessment (HTA) related frameworks, and two, an ad hoc tool. Barriers and facilitators were outlined across all CFIR domains. Implementation factors not frequently observed, such as 'evidence of previous successful tool application', 'knowledge and beliefs about the intervention' or 'external policy and incentives' were reported. Conversely, some constructs did not yield any barrier or facilitator including 'intervention source' or 'peer pressure'. PBMA studies satisfied the fidelity criteria between 86% and 100%, for MCDA it varied between 36% and 100%, and for HTA it was between 27% and 80%. However, fidelity was not related to implementation. This study is the first to use an implementation science approach. Results represent the starting point for organisations wishing to use priority setting tools in the hospital setting by providing an overview of barriers and facilitators. These factors can be used to assess readiness for implementation or to serve as the foundation for process evaluations. Through our findings, we aim to improve the uptake of priority setting tools and support their sustainable use.

15 April 2021 in Economic Record
Verified
Journal Article
Closed access
PDF file
Anam BilgramiAnam Bilgrami
Anam Bilgrami
HCHenry Cutler
Henry Cutler
KSKompal Sinha
Kompal Sinha
ZCZhiming Cheng
Zhiming Cheng

2 July 2024 in SSM - Population Health
Verified
Journal Article
Open access
Anam BilgramiAnam Bilgrami
Anam Bilgrami
MAMona Aghdaee
Mona Aghdaee
YGYuanyuan Gu
Yuanyuan Gu
HCHenry Cutler
Henry Cutler
KNKatya Numbers
Katya Numbers
HBHenry Brodaty
Henry Brodaty
Objectives: While the economic burden imposed by dementia is well-documented, findings are mixed on health care use for those with mild cognitive impairment (MCI). Our objective was to analyse annual, non-hospital medical and pharmaceutical use patterns for older people with undiagnosed MCI and diagnosed dementia, living in the Australian community. Methods: We analysed panel data from a community sample, the Sydney Memory and Ageing Study (Australia), linked to administrative data on health care use, using two-part models to estimate the probability of using health care and the annual costs incurred by study participants. Results: People with MCI, unaware of their diagnoses, were significantly less likely to incur annual pathology and diagnostic imaging costs relative to cognitively normal individuals. This effect was concentrated in individuals with MCI who had non-amnestic symptoms, lived alone, or had limited carer support. Compared to cognitively normal individuals, people with MCI were predicted to have slightly lower annual costs for broad medical care categories related to the management and diagnosis of cognitive impairment, and people with dementia, substantially higher professional attendances, and pharmaceutical costs. These findings were consistent across estimation models adjusting for attrition over the study. Policy implications: Diagnosis and symptom management in primary care may enable individuals with MCI to improve their quality of life and prevent more costly future health care use. However, our study found potential gaps in medical service use for people with undiagnosed MCI in the community, especially when they had less support or did not have memory symptoms. Primary care services may need to better diagnose and target these individuals.

17 November 2022 in Health Policy
Verified
Journal Article
Closed access
HCHenry Cutler
Henry Cutler
YGYuanyuan Gu
Yuanyuan Gu
Anam BilgramiAnam Bilgrami
Anam Bilgrami
APAndrew Partington
Andrew Partington

12 February 2024 in Applied Economics
Verified
Journal Article
Closed access
Anam BilgramiAnam Bilgrami
Anam Bilgrami
HCHenry Cutler
Henry Cutler
YGYuanyuan Gu
Yuanyuan Gu
MAMona Aghdaee
Mona Aghdaee
MGMegan Gu
Megan Gu